Analyst Research

Report Title Price
Provider: Pechala's Reports
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories Completes Separation Of Research-Based Pharmaceuticals Business


Wednesday, 2 Jan 2013 07:55am EST 

Abbott Laboratories announced it has completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company. AbbVie will begin trading independently on the New York Stock Exchange January 02, 2013 under the symbol ABBV. 

Company Quote

38.07
0.1 +0.26%
16 Apr 2014